S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

SRZN Surrozen Inc

9.94

-0.62 (-5.87%)

28 Jun 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Surrozen (NASDAQ:SRZN)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Surrozen Charts.

Surrozen (NASDAQ:SRZN)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Surrozen Charts.

Surrozen Inc News

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling
Wednesday 12 June 2024 (2 weeks ago) • GlobeNewswire Inc.

Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan
Monday 10 June 2024 (3 weeks ago) • GlobeNewswire Inc.

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
Tuesday 4 June 2024 (3 weeks ago) • GlobeNewswire Inc.

Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Thursday 9 May 2024 (2 months ago) • GlobeNewswire Inc.

Surrozen Provides First Quarter 2024 Financial Results and Business Update
Thursday 9 May 2024 (2 months ago) • GlobeNewswire Inc.

Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis
Wednesday 3 April 2024 (3 months ago) • GlobeNewswire Inc.

Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
Monday 1 April 2024 (3 months ago) • GlobeNewswire Inc.

Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules
Monday 1 April 2024 (3 months ago) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 7 February 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 7 February 2024 (5 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 23 January 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 19 January 2024 (5 months ago) • Edgar (US Regulatory)

More Surrozen Inc News Articles

Republic of Croatia

Franklin Financial Servi...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions